Sample size calculation, Feasibility, and Safety profile with Olanzapine for preventing Radiation Induced Nausea and Vomiting: Pilot Study for phase III Randomized Placebo-controlled Trial – CTRI No/2022/01/039723

Meenu Vijayan; Deb Narayan Dutta; Haridas Nair; Narmadha MP; Sheejamol VS

doi:10.52711/0974-360X.2025.00707

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Sample size calculation, Feasibility, and Safety profile with Olanzapine for preventing Radiation Induced Nausea and Vomiting: Pilot Study for phase III Randomized Placebo-controlled Trial – CTRI No/2022/01/039723

Author(s): Meenu Vijayan, Deb Narayan Dutta, Haridas Nair, Narmadha MP, Sheejamol VS

Email(s): dduttadeb07@gmail.com

DOI: 10.52711/0974-360X.2025.00707

Address: Meenu Vijayan1, Deb Narayan Dutta2*, Haridas Nair2, Narmadha MP1, Sheejamol VS3
1Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, India.
2Department of Radiation Oncology, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, India.
3Department of Biostatistics, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, India.
*Corresponding Author

Published In: Volume - 18, Issue - 10, Year - 2025

Keywords:

Cite this article:
Meenu Vijayan, Deb Narayan Dutta, Haridas Nair, Narmadha MP, Sheejamol VS. Sample size calculation, Feasibility, and Safety profile with Olanzapine for preventing Radiation Induced Nausea and Vomiting: Pilot Study for phase III Randomized Placebo-controlled Trial – CTRI No/2022/01/039723. Research Journal of Pharmacy and Technology. 2025;18(10):4902-8. doi: 10.52711/0974-360X.2025.00707

Purchase PDF